抗 原: PDHA1
技術(shù)規(guī)格
Background: |
The pyruvate dehydrogenase (PDH) complex is a nuclear-encoded mitochondrial multienzyme complex that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and provides the primary link between glycolysis and the tricarboxylic acid (TCA) cycle. The PDH complex is composed of multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3). The E1 enzyme is a heterotetramer of two alpha and two beta subunits. This gene encodes the E1 alpha 1 subunit containing the E1 active site, and plays a key role in the function of the PDH complex. Mutations in this gene are associated with pyruvate dehydrogenase E1-alpha deficiency and X-linked Leigh syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Applications: |
WB, IF |
Name of antibody: |
PDHA1 |
Immunogen: |
Fusion protein of human PDHA1 |
Full name: |
pyruvate dehydrogenase E1 alpha 1 subunit |
Synonyms: |
PDHA; PDHAD; PHE1A; PDHCE1A |
SwissProt: |
P08559 |
WB Predicted band size: |
43 kDa |
WB Positive control: |
293, 1299, mEsc and Tc1 cell lysates |
WB Recommended dilution: |
1000-5000 |
IF positive control: |
Hela cells |
IF Recommend dilution: |
50-100 |